- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-18-0126278

About Tulip Lab Private Limited
Data last updated:
Tulip Lab Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 March 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51397MH2004PTC414474. Its GSTIN is 27AACCT0325L1ZE (Maharashtra). The company holds 7 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹4.96 Cr. It is led by directors including Tushar Kumar and Rajni Rahul Pandey.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2023, the company reported a revenue of ₹38.12 Cr, a decline of 78% compared to the previous year. For the same year it recorded a net profit of ₹1.12 Cr (net margin 2.9%) and EBITDA of ₹2.93 Cr (EBITDA margin 7.7%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 9% over five years.
The company has about 75 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Tulip Lab. As per MCA filings, the company has open charges of ₹39.64 Cr and satisfied charges of ₹212.53 Cr on record. Court records list 13 cases involving the company, including 8 filed by the company and 5 filed against it; 6 cases are pending. The company has 3 deals on record (1 rights issue, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹7.99 Cr; the latest was in March 2023. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Bio Medica Laboratories Limited with revenue of ₹38.33 Cr. The company has 5 MSME Form 1 returns on record between 2019 and 2022, listing 36 overdue payments to 22 micro and small suppliers.
Tulip Lab Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0126278). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tuliplab.com.
Company details
CIN history
Tulip Lab has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U51397MH2004PTC414474, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51397MH2004PTC414474 | Current |
| U51397BR2004PTC010634 | Previous |
| U00093BR2004PTC010634 | Previous |
Recognitions & Rankings of Tulip Lab
Contact details
Tulip Lab Private Limited's registered office is in Mumbai, Maharashtra. Its website is tuliplab.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressGala 3067 Oberoi Garden, Saki Naka Road Near Chandivali Studio, Mumbai, Maharashtra, India – 400072
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Tulip Lab Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Tulip Lab operates one associated brand: Tulip Lab. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, herbal products, and clinical research services in India. | tuliplab.com |
Business activity
The main business activity of Tulip Lab is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Tulip Lab Private Limited, buy the company report.
Financials of Tulip Lab Private Limited
FY 2023 filings availableTulip Lab Private Limited reported revenue of ₹38.12 Cr (down 78% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 78% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA rose 133% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.93 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.12 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.7% | ||||
| Net Profit Margin | 2.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Tulip Lab Private Limited, buy the company report.
Board of directors of Tulip Lab Private Limited
Tulip Lab has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tushar Kumar Also directs: Siddhant Management LLP, Pharmac Medizen Health Solutions Private Limited, Aspireville Private Limited and 4 more | Director | 11 Mar 2004 | 22 Years 7 Months | Current |
| Rajni Rahul Pandey Also directs: Amentus Enterprise LLP | Director | 30 Mar 2021 | 5 Years 6 Months | Current |
| Prashant Singh Also directs: Siddhant Management LLP, Pharmac Medizen Health Solutions Private Limited, Aspireville Private Limited and 3 more | Director | 11 Mar 2004 | 22 Years 7 Months | Current |
Peer comparison
Tulip Lab Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bio Medica Laboratories Limited | ₹38.33 Cr (FY 2025) | 150.0% | Indore, Madhya Pradesh, India | |||
| Medicamen Organics Limited. | ₹38.28 Cr (FY 2025) | 51.0% | New Delhi, Delhi, India | |||
| Diamond Drugs Private Limited | ₹38.26 Cr (FY 2024) | 2.0% | Kolkata, West Bengal, India | |||
| Klar Sehen Pvt Ltd | ₹38.16 Cr (FY 2016) | 18.0% | Bidar, Karnataka, India | |||
| Tulip Lab Private Limitedthis company | ₹38.12 Cr (FY 2023) | ₹1.12 Cr | 2.9% | -78.0% | 75 | Mumbai, Maharashtra, India |
| Biomax Biotechnics Private Limited | ₹38.1 Cr (FY 2025) | 9.0% | Chandigarh, India | |||
| Zivira Labs Private Limited | ₹38.07 Cr (FY 2025) | 22.0% | Mumbai, Maharashtra, India | |||
| VVR Organics Private Limited | ₹38.01 Cr (FY 2024) | 9.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Tulip Lab Private Limited, buy the company report.
Auditor
Tulip Lab Private Limited is audited by Y R & Associates for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Y R & Associates | FY 2022 | 135722W |
Shareholding
The shareholding of Tulip Lab Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Tulip Lab Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Aug 2025 | 101158681 | Others | ₹15 Cr | Open | |
| 15 Mar 2024 | 100890228 | Others | ₹15 Cr | Open | |
| 10 Jul 2023 | 100772728 | Hdfc Bank Limited | ₹9.64 Cr | Open | |
| 20 Jul 2022 | 100606729 | Others | ₹80 Cr | Satisfied | |
| 14 Mar 2022 | 100557404 | Hdfc Bank Limited | ₹8 Cr | Satisfied |
To see the full charge records of Tulip Lab Private Limited, buy the company report.
Total charge records: 11 View all charges
Deals & funding
Tulip Lab Private Limited has 3 deals on record (1 rights issue, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹7.99 Cr; the latest was in March 2023.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | Funding round · Series A | ₹7.99 Cr | Investors: 2 individuals |
| Mar 2020 | Rights issue | ₹3.98 Cr | Investors: 2 individuals |
| Mar 2008 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Tulip Lab Private Limited has 13 court cases on record: 8 filed by Tulip Lab, 5 filed against it. 6 cases are pending and 7 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 6 | 0 | 1 |
| NCLAT | 5 | 5 | 4 |
| District courts | 2 | 0 | 1 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLAT, NCLAT New Delhi | Interim or miscellaneous application | Filed against the company by Glendale Biomed Private Limited | Pending |
| NCLAT, NCLAT New Delhi | Insolvency matter | Filed against the company by Glendale Biomed Private Limited | Pending |
| NCLAT, NCLAT New Delhi | Interim or miscellaneous application | Filed against the company by Glendale Biomed Private Limited | Disposed |
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (Ref.IDA) | Filed by the company against an individual | Pending |
| High Court, MAHARASHTRA | Writ petition | Filed by the company against State of Maharashtra | Pending |
To see the full case history of Tulip Lab Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Tulip Lab Private Limited has 5 MSME Form 1 returns on record between 2019 and 2022, listing 36 overdue payments to 22 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 22)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Thermolab Testing Services Private Limited | |||
| an individual supplier | |||
| Y R & Associates | |||
| Envirocare Labs Private Limited | |||
| Ideal Cures Private Limited |
To see the full MSME payment records of Tulip Lab Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Tulip Lab Private Limited has a workforce of 75 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Tulip Lab has 7 GST registrations: 1 active and 6 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCT0325L1ZE | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Tulip Lab Private Limited, buy the company report.
Recent activity
Tulip Lab Private Limited has 5 board changes on record since 2004: 3 appointments and 2 cessations. The latest: Rajni Rahul Pandey ceased to be Additional Director on 30 Nov 2021.
20 earlier events are in the company report.
Frequently asked questions
Tulip Lab is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 March 2004 (22+ years old) and is registered under CIN U51397MH2004PTC414474.
Tulip Lab has 3 current directors:
- Tushar Kumar - Director
- Rajni Rahul Pandey - Director
- Prashant Singh - Director
The latest financial statements of Tulip Lab on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Tulip Lab is 27AACCT0325L1ZE, registered in Maharashtra. The company has 7 GST registrations in all, of which 1 is active and 6 are cancelled or inactive.
The CIN (Corporate Identification Number) of Tulip Lab is U51397MH2004PTC414474. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tulip Lab has 13 court cases on record: 8 filed by the company and 5 filed against it. 6 are pending. Most are in the high courts.
Tulip Lab was incorporated on 11 March 2004, making it 22+ years old. It is registered with the Registrar of Companies, Mumbai.
Tulip Lab has 3 deals on record (1 rights issue, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹7.99 Cr; the latest was in March 2023.
The peers of Tulip Lab by revenue are Bio Medica Laboratories Limited, Medicamen Organics Limited, Diamond Drugs Private Limited, Klar Sehen Pvt Ltd, Biomax Biotechnics Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rajni Rahul Pandey ceased to be Additional Director on 30 Nov 2021. Rajni Rahul Pandey was appointed as Director on 30 Mar 2021. Arunabh Ramdarsan Thakur ceased to be Director on 30 Sep 2007. Tulip Lab has 5 board changes on record in total.
Yes, Tulip Lab is registered as a small enterprise under Udyam registration (number: UDYAM-MH-18-0126278).
Tulip Lab has 5 MSME Form 1 returns on record between 2019 and 2022, listing 36 overdue payments to 22 micro and small suppliers. The latest return was filed on 30 Apr 2022.